FDA Inspection 1053615 — Eagle Pharma Outsourcing LLC
The FDA completed an inspection of Eagle Pharma Outsourcing LLC on May 18, 2018 in Hoover, AL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- May 18, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hoover, AL (United States)